UCD researcher develops new epilepsy treatment methods

Sujithra Srinivas is a PhD researcher at University College Dublin. She focuses on epilepsy, a neurological disorder affecting over 50 million people worldwide. Srinivas aims to create practical treatments for this condition through her research. Srinivas highlights the importance of translational research. This type of research bridges the gap between laboratory findings and real-world applications. One of her outreach projects, called 'Cut from the Same Cloth,' connects women by sharing stories about textiles and relating them to scientific themes. Her current research explores genetic and environmental factors contributing to epilepsy. Many patients do not respond to traditional medication, driving interest in new therapies. Specifically, she studies a process called m6A modification in RNA, which affects gene regulation. Improving treatment outcomes is a key goal. Current epilepsy drugs mostly manage symptoms rather than address underlying causes. By focusing on certain enzymes, Srinivas hopes to develop strategies that not only control seizures but also slow disease progression. Funding challenges are a significant hurdle for researchers like Srinivas. Gaining financial support for innovative studies can be difficult due to competition for grants. Additionally, systemic biases can limit the representation of women in STEM fields, affecting opportunities for collaboration and leadership. Srinivas also notes changes in how the public engages with science. The Covid-19 pandemic raised awareness of scientific processes, leading to greater trust in scientific institutions. However, the politicization of science remains a concern, making public discussions more polarized. Overall, Srinivas is dedicated to advancing epilepsy research and improving the lives of those affected by the condition. She believes in the power of early intervention and continues to work towards meaningful discoveries in neuroscience.